433
Views
32
CrossRef citations to date
0
Altmetric
Original Article

Prediction of age at menopause in women with polycystic ovary syndrome

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 29-34 | Received 05 Aug 2017, Accepted 11 Oct 2017, Published online: 06 Nov 2017
 

Abstract

Objective: Considering the role of anti-Müllerian hormone (AMH) in female fertility and its high levels in women with polycystic ovary syndrome (PCOS), the longer reproductive span of these women is in doubt. In the present study, we aimed to improve earlier predictions using a non-linear model to substantiate the question as to whether PCOS women reach menopause later.

Methods: In total, 1162 women aged 20–50 years, comprising 378 PCOS cases and 784 eumenorrheic non-hirsute women, met the eligibility criteria. A scatterplot matrix was drawn to detect the association between age and AMH; this association was explored using a fractional polynomial regression model. Model assumptions were checked by examining the distribution of the residuals and plotting the standardized residuals against the functional form of AMH.

Results: The serum concentration of AMH among PCOS participants was significantly higher than in the controls (5.4 ng/ml (IQR 2.8–9.1 ng/ml) vs. 1.4 ng/ml (IQR 0.6–2.7 ng/ml), p < 0.001). The estimated mean age at menopause was 51.4 (95% CI 45–59) years and 49.7 (95% CI 45–55) years in PCOS cases and healthy controls, respectively.

Conclusions: These findings provide the insight that, as reflected through significantly higher average levels of AMH in PCOS women, their predicted reproductive lifespan could be 2 years longer than their normo-ovulatory counterparts.

Acknowledgements

The authors wish to acknowledge Ms. Niloofar Shiva for the critical editing of English grammar and syntax of the manuscript.

Conflict of interest

The authors report no conflict of interest. The authors alone are responsible for the content and writing of this paper.

Additional information

Funding

This study was supported by the Research Institute for Endocrine Sciences (RIES), Shahid Beheshti University of Medical Sciences [grant number: 348].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.